thus , in the mouse , the newly discovered intrapancreatic peptide pancreastatin 1 ) lowers baseline plasma insulin levels , 2 ) inhibits glucose- and cholinergically induced insulin secretion , 3 ) stimulates baseline glucagon secretion , and 4 ) induces hyperglycemia .
C0017725
glucose
C0020456
hyperglycemia